- Full Circle Investments plans $30M fund, http://ow.ly/1eMhh #
- OSI shareholder tells Astellas to increase takeover bid by 15%, http://ow.ly/1eM9w #
- Study identifies two types of self-renewing blood cells, http://ow.ly/1eMaW #
- Study: Vaccine triggers immune response against mesothelioma, http://ow.ly/1eMbI #
- Bristol-Myers details strategy to offset future Plavix losses, http://ow.ly/1eMcg #
- FDA approves immune-replacement drug Hizentra, http://ow.ly/1eMd2 #
- BioVex begins Phase I trial of genital herpes vaccine in U.K., http://ow.ly/1eMea #
- Dow AgroSciences to spend $340M on research expansion in Indianapolis, http://ow.ly/1eMfG #
- Arizona Technology Enterprises partners with Japan Technology Group, http://ow.ly/1eMib #
- Purdue Research Foundation establishes network for angel investors, http://ow.ly/1eMjU #
- RT @biotechmontreal: Semaine prochaine / Next week: 2010-03-16 – LAB – RSVP: http://ow.ly/1fLoW #
- RT @ogilvyrenault: Toronto and Tel Aviv Exchanges Sign MoU: Is Dual-Listing on the Horizon? http://bit.ly/dmfkmJ #
- RT @ogilvyrenault: Canada federal budget 2010: Changes in tax law favourable to international investors http://bit.ly/bnqcKi #
- RT @NeowinFeed: Steam coming to OS X in April; no repurchasing required http://neow.in/acM5Ub #
